Alignment Healthcare: Buy the Oversold Pullback After the Whistleblower Shock
Alignment Healthcare (ALHC) cratered after a whistleblower disclosure in July. The headline risk is real but materially sized relative to revenue and free cash flow. With the stock at $13.80, oversold technicals, positive free cash flow of $177.5M, and EV/sales of 0.55, this is a tactical long with defined risk and clear catalysts — legal clarity a…